EP Patent

EP2114383A2 — Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain

Assigned to Talphera Inc · Expires 2009-11-11 · 17y expired

What this patent protects

Compositions, systems and methods for administration of small volume sufentanil drug dosage forms to the sublingual mucosa of a subject for treatment of pain using a device are disclosed.

USPTO Abstract

Compositions, systems and methods for administration of small volume sufentanil drug dosage forms to the sublingual mucosa of a subject for treatment of pain using a device are disclosed.

Drugs covered by this patent

Patent Metadata

Patent number
EP2114383A2
Jurisdiction
EP
Classification
—
Expires
2009-11-11
Drug substance claim
No
Drug product claim
No
Assignee
Talphera Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.